title: Does Acute Physiologic and Chronic Health Evaluation (APACHE II) scoring predict need for prolonged support after coronary revascularization?
abstract: Significant intensive care unit (ICU) resources are allocated to patients recovering from coronary artery bypass graft (CABG) procedures, suggesting that a system to identify patients at risk for prolonged ICU therapy would help to enhance the use of this resource. To test the hypothesis that post-CABG patients likely to require prolonged ICU stay could be identified at the time of admission using the Acute Physiologic and Chronic Health Evaluation (APACHE II) system for scoring the severity of illness, we retrospectively reviewed the length of ICU stay for all patients recovering from CABG procedures over 1 yr, comparing the APACHE II scores assigned to patients requiring the longest stay with scores for patients with the briefest stay to determine whether a difference in score corresponded with the difference in length of stay. All medical records were reviewed and the physiologic variables (n = 12) used to assess acute physiologic status were recorded. Perioperative therapeutic interventions having significant impact on the physiologic variables used to derive the APACHE II score also were recorded. The study group was defined as patients requiring ICU care lasting between 14 and 84 days (n = 20); a control group of 23 patients was randomly selected from 124 patients having an ICU stay of 48 h or less. The overall APACHE II scores, and the component scores used to derive the overall scores, were calculated for both groups and were compared. The mean APACHE II score for the study group was 23.5 compared with 13.2 (P < 0.001) for the control group.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Anesthesia, University of California at San Francisco 94143-0624, USA.
authors.forename: T E
authors.initials: TE
authors.lastname: Shaughnessy
authors.forename: T A
authors.initials: TA
authors.lastname: Mickler
mesh_terms: D018806:APACHE; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use; D016022:Case-Control Studies; D001026:Coronary Artery Bypass; D003404:Creatinine / Q000097:blood; D003422:Critical Care; D005544:Forecasting; D015600:Glasgow Coma Scale; D015276:Health Care Rationing; D006801:Humans; D007423:Intra-Aortic Balloon Pumping; D007902:Length of Stay; D010343:Patient Admission; D012189:Retrospective Studies; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents; D002316:Cardiotonic Agents; D003404:Creatinine